跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SANDOZ EVEROLIMUS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SANDOZ EVEROLIMUS
Authorized
STANDARD
SANDOZ EVEROLIMUS
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6aede7545b4138a9
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
6aede7545b4138a9
Drug Approval Canada Name
SANDOZ EVEROLIMUS
Product Name
SANDOZ EVEROLIMUS
Status
Marketed
Status Date
2020-09-17
Original Market Date
2020-09-17
Din
02492938
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L04AH02 EVEROLIMUS
Atc Name
l 04 ah 02
Aig Number
0152682001
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
EVEROLIMUS
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6aede7545b4138a9
Type
Standard
Back to Health Canada Approvals